Effect of glycated LDL on microvascular tone in mice: A comparative study with LDL modified in vitro or isolated from diabetic patients

Diabetologia

Volumn 46, Issue 11, 2003, Pages 1550-1558

  Nivoit, P ^a   Wiernsperger, N ^a   Moulin, P ^b   Lagarde, M ^a   Renaudin, C ^a  

^a UNIVERSITÉ DE LYON   (France)

^b Cardiology Hospital   (France)

Author keywords

Arteriole; Glycated LDL; Microcirculation; Mouse; OPS imaging; Skeletal muscle

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; GLYCATION; HUMAN; MALE; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; TRAPEZIUS MUSCLE; VASOCONSTRICTION;

ANIMALS; ARTERIOLES; DIABETES MELLITUS; GLYCOSYLATION; HUMANS; LIPOPROTEINS, LDL; MICE; MICROCIRCULATION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; SPECIES SPECIFICITY;

EID: 0345117400     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1225-2     Document Type: Article

References (50)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853
3. Brownlee M (1992) Nonenzymatic glycosylation of macromolecules. Prospects of pharmacologic modulation. Diabetes 41 [Suppl 2]:57-60
4. Kennedy AL, Merimee TJ (1981) Glycosylated serum protein and hemoglobin A1 levels to measure control of glycemia. Ann Intern Med 95:56-58
5. Danze PM, Tarjoman A, Rousseaux J, Fossati P, Dautrevaux M (1987) Evidence for an increased glycation of IgG in diabetic patients. Clin Chim Acta 166:143-153
6. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976) Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 295:417-420
7. Lyons TJ (1992) Lipoprotein glycation and its metabolic consequences. Diabetes 41 [Suppl 2]:67-73
8. Schleicher E, Deufel T, Wieland OH (1981) Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilon-lysine glycosylated low density lipoprotein in diabetic patients. FEBS Lett 129:1-4
9. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438
10. Graier WF, Kostner GM (1997) Glycated low-density lipoprotein and atherogenesis: the missing link between diabetes mellitus and hypercholesterolaemia? Eur J Clin Invest 27:457-459
11. Steinbrecher UP, Witztum JL (1984) Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33:130-134
12. Lopes-Virella MF, Sherer GK, Lees AM et al. (1982) Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 22:430-436
13. Edwards IJ, Wagner JD, Litwak KN, Rudel LL, Cefalu WT (1999) Glycation of plasma low density lipoproteins increases interaction with arterial proteoglycans. Diabetes Res Clin Pract 46:9-18
14. Sobal G, Menzel J, Sinzinger H (2000) Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids 63:177-186
15. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH (1993) Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 102:63-67
16. Ferretti G, Rabini RA, Bacchetti T et al. (2002) Glycated low density lipoproteins modify platelet properties: a compositional and functional study. J Clin Endocrinol Metab 87:2180-2184
17. Lyons TJ, Li W, Wells-Knecht MC, Jokl R (1994) Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes. Diabetes 43:1090-1095
18. Jenkins AJ, Velarde V, Klein RL et al. (2000) Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes 49:2160-2169
19. Gray SD (1973) Rat spinotrapezius muscle preparation for microscopic observation of the terminal vascular bed. Microvasc Res 5:395-400
20. Nivoit P, Renaudin C, Lagarde M, Wiernsperger N (2001) Mouse spinotrapezius muscle preparation for microscopic study of skeletal muscle vascular resistance bed: prospective studies with ox-LDL. Proceedings of the 7th World Congress for Microcirculation P2-25 (Abstract)
21. Groner W, Winkelman JW, Harris AG et al. (1999) Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 5:1209-1212
22. Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212-216
23. Posch K, Simecek S, Wascher TC et al. (1999) Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes 48:1331-1337
24. Duell PB, Oram JF, Bierman EL (1990) Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes 39:1257-1263
25. Nivoit P, Renaudin C, Lagarde M, Wiernsperger N (2002) Visualisation of the mouse skeletal muscle microcirculation by OPS imaging system: Validation with vasoactive drugs. Proceedings of the 3rd International Amsterdam Mouse Symposium
26. Diehl KH, Hull R, Morton D et al. (2001) A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21:15-23
27. Akanji AO, Abdella N, Mojiminiyi OA (2002) Determinants of glycated LDL levels in nondiabetic and diabetic hyperlipidaemic patients in Kuwait. Clin Chim Acta 317:171-176
28. Lyons TJ, Baynes JW, Patrick JS, Colwell JA, Lopes-Virella MF (1986) Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control. Diabetologia 29:685-689
29. Klein RL, Laimins M, Lopes-Virella MF (1995) Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes 44:1093-1098
30. Moro E, Alessandrini P, Zambon C et al. (1999) Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition? Diabet Med 16:663-669
31. Sanguinetti SM, Schreier LE, Elbert A, Fasulo V, Ferrari N, Wikinski RL (1999) Detection of structural alterations in LDL isolated from type 2 diabetic patients: application of the fructosamine assay to evaluate the extent of LDL glycation. Atherosclerosis 143:213-215
32. Cox DA, Cohen ML (1996) Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol Rev 48:3-19
33. Nivoit P, Renaudin C, Lagarde M, Wiernsperger N (2002) In vivo microvascular responses to native and oxidized low density lipoprotein in mouse spinotrapezius muscle. Diabetes 51 [Suppl 2] A496 2038-PO (Abstract)
34. Sibley SD, Hokanson JE, Steffes MW et al. (1999) Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes. Diabetes Care 22:1165-1170
35. Haffner SM (2002) Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol 90:55-6136
36. Kwiterovich PO Jr (1988) HyperapoB: a pleiotropic phenotype characterized by dense low-density lipoproteins and associated with coronary artery disease. Clin Chem 34:B71-B77
37. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM (1992) LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12:1496-1502
38. Austin MA, Edwards KL (1996) Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr Opin Lipidol 7:167-171
39. 2α from low density lipoprotein during its in vitro oxidation. Prostaglandins Leukot Essent Fatty Acids 62:217-224
40. 2α on retinal circulation in diabetic and non-diabetic rats. Prostaglandins Leukot Essent Fatty Acids 59:349-355
41. Romerio SC, Linder L, Flammer J, Haefeli WE (2000) Correlation between apolipoprotein B and endothelin-1-induced vasoconstriction in humans. Peptides 21:871-874
42. Jenkins AJ, Li W, Moller K et al. (1999) Pre-enrichment of modified low density lipoproteins with alpha-tocopherol mitigates adverse effects on cultured retinal capillary cells. Curr Eye Res 19:137-145
43. De Vriese AS, Verbeuren TJ, van d, V, Lameire NH, Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974
44. Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD (1997) Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 96:3287-3293
45. Kaufmann PA, Gnecchi-Ruscone T, Schafers KP, Luscher TF, Camici PG (2000) Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 36:103-109
46. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340:1430-1432
47. Clarkson P, Celermajer DS, Donald AE et al. (1996) Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 28:573-579
48. McVeigh GE, Brennan GM, Johnston GD et al. (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:771-776
49. Van Etten RW, Koning EJ de, Honing ML, Stroes ES, Gaillard CA, Rabelink TJ (2002) Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 22:799-804
50. McNeill KL, Fontana L, Russell-Jones DL, Rajman I, Ritter JM, Chowienczyk PJ (2000) Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation. J Am Coll Cardiol 35:1622-1627